Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study

Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study

Background: There is a tendency to decrease the intensity of breast cancer treatments, e.g. omitting adjuvant chemotherapy in endocrine-sensitive and HER-2 negative patients. The purpose of this study was to analyse changes in the frequency of the indication of adjuvant chemotherapy and the differe...

Full description

Bibliographic Details
Main Authors: José Manuel Baena Cañada, Carlos de la Torre Hita, Marta Bernal Gómez, Alicia Campini Bermejo, Salvador Gámez Casado, Lourdes Rodríguez Pérez, Alicia Quílez Cutillas, Julio Calvete Candenas, Sara Estalella Mendoza, Encarnación Benítez Rodríguez
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2021-07-01
Series:Archives of Breast Cancer
Subjects:
Breast neoplasm
Hormonal Antineoplastic Agents
Adjuvant Chemotherapy
Survival
Systemic adjuvant therapies
Online Access:https://www.archbreastcancer.com/index.php/abc/article/view/409

Internet

https://www.archbreastcancer.com/index.php/abc/article/view/409

Similar Items